Severe respiratory syncytial virus (RSV)-induced disease is associated with
childhood asthma and atopy. We combined models of allergen sensitization a
nd RSV infection to begin exploring the immunologic interactions between al
lergic and virus-induced airway inflammation and its impact on airway hyper
sensitivity. Airway resistance was measured after methacholine challenge in
tracheally intubated mice by whole body plethysmography. Lung inflammation
was assessed by bronchoalveolar lavage (BAL) and histopathology. RSV infec
tion alone did not cause significant airway hyperresponsiveness (AHR) to me
thacholine. Ovalbumin (OVA)induced AHR lasted only a few days past the disc
ontinuance of OVA aerosol in mice that were ovalbumin sensitized and mock i
nfected. In contrast, OVA-sensitized mice infected with RSV during the OVA
aerosol treatments (OVA/RSV) had AHR for more than 2 weeks after infection.
However, 2 weeks after either RSV or mock infection, OVA/RSV mice had sign
ificantly more lymphocytes found during BAL than OVA mice, whereas the OVA
and OVA/RSV groups had the same number of eosinophils. Histopathologic anal
ysis confirmed an increased inflammation in the lungs of OVA/RSV mice compa
red with OVA mice. In addition, OVA/RSV mice had a more widespread distribu
tion of mucus in their airways with increased amounts of intraluminal mucus
pools compared with the other groups. Thus, prolonged AHR in RSV-infected
mice during ovalbumin-sensitization correlates with increased numbers of ly
mphocytes in BAL fluid, increased lung inflammation, and mucus deposition i
n the airways, but not with airway eosinophilia. A further understanding of
the immunologic consequences of combined allergic and virus-induced airway
inflammation will impact the management of diseases associated with airway
hyperreactivity. (C) 1999 Wiley-Liss, Inc.